Psychiatric comorbidity in methadone maintained patients.

Psychiatric comorbidity in methadone maintained patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Psychiatric comorbidity in methadone maintained patients. Abstract Text:

Diagnosing comorbid psychiatric disorders in methadone maintained patients may help to identify subgroups with different outcomes and needs for treatment. In this study, 75 methadone maintenance clinic patients in treatment longer than 30 days were assessed with the Addiction Severity Index, Global Assessment Scale and Mini-Mental Status Exam, and were interviewed for DSM-III-R psychiatric diagnosis using the computerized Diagnostic Interview Schedule. Psychiatric diagnoses were prevalent in the sample with depression, phobic disorders, antisocial personality and generalized anxiety the most common. Both number of DSM-III-R diagnoses and severity of psychopathology were correlated with outcome measures such as concurrent drug abuse, family-social problems and employment status.

Psychiatric comorbidity in methadone maintained patients. Publishing Authors By Initials

For similar behavioral disciplines and activities: psychiatric status rating scales research abstracts see: behavioral disciplines and activities: psychiatric status rating scales research

PUBMED ID PMID:

MEDLINE DATE:

Psychiatric comorbidity in methadone maintained patients. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Journal of addictive diseases

VOLUME: 17

Page Numbers: 75-89

Journal Abbreviation:

ISSN: 1055-0887

DAY: 12

MONTH: 05

YEAR: 1998

Psychiatric comorbidity in methadone maintained patients. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9107051

Psychiatric comorbidity in methadone maintained patients. Keywords Mesh Terms:

KEYWORDS: Psychiatric Status Rating Scales

MESH TERMS: epidemiology

Chemical & Substance for Abstract: Psychiatric comorbidity in methadone maintained patients. Information

Substance Name: Methadone

Registry Number: 76-99-3

Grant and Affiliation Information for Psychiatric comorbidity in methadone maintained patients.

AFFILIATION: Laboratory of the Biology of Addictive Diseases, Rockefeller University, New York, NY, USA.

Country: UNITED STATES

AGENCY: United States NIDA

GRANT: DA-05130

ACRONYM: DA

MEDLINETA: J Addict Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Psychiatric comorbidity in methadone maintained patients Related Publications

• Adolescent and young adult heroin patients: drug use and success in methadone maintenance treatment.
• Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction.
• Availability of reliable serum methadone determination for management of symptomatic patients.
• Clock reset for alcoholism.
• Cocaine abuse sharply reduced in an effective methadone maintenance program.
• Cocaine, dopamine and the endogenous opioid system.
• Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients.
• Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.
• Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate microarray analysis.
• Downregulation of kappa-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose "binge" cocaine administration paradigm.
• Effects of acute "binge" cocaine on mRNA levels of mu opioid receptor and neuropeptides in dopamine D1 or D3 receptor knockout mice.
• Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans.
• Extracellular biotransformation of beta-endorphin in rat striatum and cerebrospinal fluid.
• Genotype patterns that contribute to increased risk for or protection from developing heroin addiction.
• Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment.
• Involvement of arginine vasopressin and v1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin.
• Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates.
• Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis B.
• Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal.
• On blending practice and research: the search for commonalities in substance abuse treatment.
• Opioids, dopamine, stress, and the addictions.
• Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence.
• Psychiatric comorbidity in methadone maintained patients.
• Role of a functional human gene polymorphism in stress responsivity and addictions.
• Stress, dysregulation of drug reward pathways, and the transition to drug dependence.
• TPH2 and TPH1: Association of Variants and Interactions with Heroin Addiction.
• The BiolAD-DB system : an informatics system for clinical and genetic data.
• The effects of drug abuse on the stress responsive hypothalamic-pituitary-adrenal axis and the dopaminergic and endogenous opioid systems.
• The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.
• The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.